Mendoza MTJ, Morales MMP, Jiménez PML, Escobedo AF

Language: Spanish
References: 12
Page: 183-193
PDF size: 100.73 Kb.

ABSTRACT

Objective: To determine the fetal lung maturity in a group of pregnant patients complicated by gestational diabetes or impaired glucose tolerance, metabolic controlled patients, as well as to identify the modifications of the phospholipids lung profile by effect of antenatal steroids.
Patients and methods: 231 pregnant patients were included in an observational, longitudinal, clinical and descriptive study from January 1st 2000 to April 30th 2003. All those included presented gestational diabetes or impaired glucose tolerance according to the criteria of Carpenter. The metabolic control was demonstrated by means of glycosylated hemoglobin figures minor to 6.5%, and glucose monitoring (‹ 95 mg/dL before meals and ‹ 120 mg/dL two hours after each meal). The amniocentesis was performed just before the use of antenatal steroids and 48 hours after. The phospholipids lung profile was performed applying the Hallman and Kulovich method.
Results: By means of the Student’s t-test non significant results were obtained for the general characteristics of both groups, except for the evolution of the phospholipids lung profile in the post-treatment group with antenatal steroids. As for the evolution of the fractions in the profile of the weekly phospholipids, an ANOVA test was applied with a p ‹ 0.001 coefficient of statistical significance for the phosphatidylglycerol fraction.
Conclusions: Delay of fetal lung maturity was shown in all the fractions of the phospholipids lung profile. In the group of patients with pregnancies of 36 weeks or more there was shown no correspondence among gestational age and the state of fetal lung maturity (60.75%), in comparison to that reported in existing literature. There were not reported cases of respiratory distress syndrome in the newborns.

REFERENCES

1. Jovanovic-Peterson L, Peterson CM. Review of gestational diabetes mellitus and low calorie diet and physical exercise therapy. Diabetes Metab Rev 1996;12:287-308.

2. Darcy B, Garbe S. Gestational diabetes, detection, management and implications. Clin Diabetes 1998;16(1):187-95.

3. Bolaños R, Ambás A, Zea P, Herrerías T, Barranco A. Análisis de la prueba de 50 gramos de glucosa en el Instituto Nacional de Perinatología. Ginecol Obstet Mex 1997;65:52-55.

4. Rivera-Bolaños R. Hijo de madre diabética. Rev Perinatol 1998;13(4):2-7.

5. Conway D, Langer O. Effects of new criteria for type 2 dibetes on the rate of postpartum glucose intolerance in women with gestational diabetes. Am J Obstet Gynecol 1999;181:610-4.

6. Constan BE. The organizing committee. Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care 1998;21(Suppl 2):B161-89.

7. González de Aguero R, Fabre G. Nutrición y dietética durante el embarazo. Barcelona: Masson, 1996;p:39.

8. Kjos SL, Walther F. Prevalence and etiology of respiratory distress in infants of diabetic mothers: Predictive valor of lung maduration test. Am J Obstet Gynecol 1990;163:898.

9. Piper J, Oded L. Does maternal diabetes delay fetal pulmonary maturity? Am J Obstet Gynecol 1993;168:783-6.

10. Pryhuber G, Hull W, Fink I, et al. Ontogeny of surfactant proteins A and B in human amniotic fluid as indices of fetal lung maturity. Pediatr Res 1991;30:597-605.

11. De Roche M, Ingardia Ch, et al. The use of lamellar body counts to predict fetal lung maturity in pregnancies complicated by diabetes mellitus. Am J Obstet Gynecol 2002;187:908-12.

12. Ballard MJ. Hormonoterapia prenatal para maduración del pulmón fetal. Clin Perinatol 1998;p:1034.